Resultados globales: 2 registros encontrados en 0.02 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
1.
17 p, 4.8 MB ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer / Devis, Laura (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martinez-Garcia, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Moiola, Cristian P. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Quiles, Maria Teresa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Arbós i Via, Maria Antònia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Stirbat, Tomita Vasilica (Institut Curie, CNRS, Paris, France) ; Brochard-Wyart, Françoise (Institut Curie, CNRS, Paris, France) ; García, Ángel (Hospital Universitari Vall d'Hebron) ; Alonso-Alconada, Lorena (Translational Laboratory, Medical Oncology Department, Complexo Hospitalario Universitario de Santiago, SERGAS, CIBERONC, Santiago de Compostela, Spain) ; Abal, Miguel (Translational Laboratory, Medical Oncology Department, Complexo Hospitalario Universitario de Santiago, SERGAS, CIBERONC, Santiago de Compostela, Spain) ; Diaz-Feijoo, Berta (Hospital Universitari Vall d'Hebron) ; Thomas, William (Department of Natural Sciences, Colby-Sawyer College, New London, New Hampshire, United States of America) ; Dufour, Sylvie (Present address: Université Paris Est, Faculté de Médecine, Créteil, France, INSERM, U955, Equipe 6, Créteil, France) ; Mancebo, Gemma (Hospital del Mar (Barcelona)) ; Alameda, Francesc (Hospital del Mar (Barcelona)) ; Reventos, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gil-Moreno, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Colas, Eva (Biomedical Research Group in Gynecology, Vall Hebron Research Institute, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain) ; Universitat Autònoma de Barcelona
Endometrial cancer (EC) is the sixth deadliest cancer in women. The depth of myometrial invasion is one of the most important prognostic factors, being directly associated with tumor recurrence and mortality. [...]
2018 - 10.18632/oncotarget.24625
Oncotarget, Vol. 9 (march 2018) , p. 16648-16664  
2.
14 p, 5.6 MB Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples / Martinez-Garcia, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Lesur, Antoine (Luxembourg Clinical Proteomics Center (LCP), Luxembourg Institute of Health (LIH), Strassen, Luxembourg) ; Devis, Laura (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Campos, Alexandre (Sanford-Burnham Medical Research Institute, La Jolla, California, USA) ; Cabrera, Silvia (Hospital Universitari Vall d'Hebron) ; van Oostrum, Jan (Luxembourg Clinical Proteomics Center (LCP), Luxembourg Institute of Health (LIH), Strassen, Luxembourg) ; Matias-Guiu, Xavier (Pathological Oncology Group and Pathology Department, Hospital Arnau de Vilanova, Lleida, Spain) ; Gil-Moreno, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Reventos, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Colas, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Domon, Bruno (Luxembourg Clinical Proteomics Center (LCP), Luxembourg Institute of Health (LIH), Strassen, Luxembourg) ; Universitat Autònoma de Barcelona
About 30% of endometrial cancer (EC) patients are diagnosed at an advanced stage of the disease, which is associated with a drastic decrease in the 5-year survival rate. The identification of biomarkers in uterine aspirate samples, which are collected by a minimally invasive procedure, would improve early diagnosis of EC. [...]
2016 - 10.18632/oncotarget.10632
Oncotarget, Vol. 7 (july 2016) , p. 53102-53115  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.